Process View
The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cell adhesion mediated by integrin"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 1.000 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.991 | ||
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.925 | Human | |
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.915 | ||
| FLNA | filamin A, alpha | 0.852 | ||
| FN1 | fibronectin 1 | 0.807 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.795 | ||
| FHL2 | four and a half LIM domains 2 | 0.778 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.768 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.749 | ||
| PLAU | plasminogen activator, urokinase | 0.685 | ||
| EPHA2 | EPH receptor A2 | 0.593 | ||
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.529 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.528 | ||
| ENG | endoglin | 0.513 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.477 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.414 | Human Mouse | |
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.343 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.296 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.286 | Mouse | |
| CCL2 | chemokine (C-C motif) ligand 2 | 0.279 | Human | |
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.275 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.214 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.192 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.171 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.171 | ||
| MSN | moesin | 0.153 | ||
| THBS1 | thrombospondin 1 | 0.141 | Fly | |
| PXN | paxillin | 0.141 | ||
| IL1B | interleukin 1, beta | 0.131 | ||
| ITGA6 | integrin, alpha 6 | 0.112 | Human Mouse Worm | |
| TLN1 | talin 1 | 0.111 | Human | |
| IL8 | interleukin 8 | 0.105 | ||
| NRP2 | neuropilin 2 | 0.103 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.103 | ||
| PLEC | plectin | 0.101 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.098 | ||
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.092 | Human | |
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.087 | ||
| ITGB4 | integrin, beta 4 | 0.086 | Human | |
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.085 | ||
| EPHA7 | EPH receptor A7 | 0.076 | Human | |
| ZNF746 | zinc finger protein 746 | 0.072 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.071 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.069 | ||
| ARPC2 | actin related protein 2/3 complex, subunit 2, 34kDa | 0.068 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.066 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.062 | ||
| EFNA1 | ephrin-A1 | 0.061 | ||
| RANBP9 | RAN binding protein 9 | 0.061 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.059 | ||
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.058 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.057 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.056 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.056 | ||
| VCL | vinculin | 0.056 | ||
| PFN1 | profilin 1 | 0.055 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.055 | ||
| OSMR | oncostatin M receptor | 0.055 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.054 | Human | |
| TNC | tenascin C | 0.054 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.053 | ||
| ABI2 | abl-interactor 2 | 0.053 | Fly | |
| ZYX | zyxin | 0.052 | ||
| HMG20A | high mobility group 20A | 0.048 | ||
| NCKAP1 | NCK-associated protein 1 | 0.048 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.047 | Human Worm | |
| ANGPTL4 | angiopoietin-like 4 | 0.047 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.045 | Human | |
| SNX9 | sorting nexin 9 | 0.045 | ||
| CYTH1 | cytohesin 1 | 0.044 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.044 | ||
| PLAT | plasminogen activator, tissue | 0.043 | Human | |
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.043 | ||
| DLG1 | discs, large homolog 1 (Drosophila) | 0.043 | ||
| EFNA5 | ephrin-A5 | 0.042 | Human | |
| HCLS1 | hematopoietic cell-specific Lyn substrate 1 | 0.042 | ||
| MYO10 | myosin X | 0.041 | ||
| IL7R | interleukin 7 receptor | 0.040 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.039 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.038 | Human | |
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.038 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.037 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.037 | Human | |
| GAB1 | GRB2-associated binding protein 1 | 0.037 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.036 | ||
| FXYD5 | FXYD domain containing ion transport regulator 5 | 0.034 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.034 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.033 | Human | |
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.033 | ||
| IDE | insulin-degrading enzyme | 0.033 | ||
| ITGA4 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | 0.032 | Human | |
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.032 | ||
| MAD2L2 | MAD2 mitotic arrest deficient-like 2 (yeast) | 0.032 | ||
| INHBA | inhibin, beta A | 0.032 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.031 | ||
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.031 | ||
| CALD1 | caldesmon 1 | 0.030 | ||
| SELPLG | selectin P ligand | 0.030 | ||
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.030 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.029 | ||
| PLEK | pleckstrin | 0.029 | ||
| SH3D19 | SH3 domain containing 19 | 0.028 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.027 | ||
| TCF4 | transcription factor 4 | 0.027 | ||
| LMNA | lamin A/C | 0.027 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.027 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.027 | Human | |
| SOCS3 | suppressor of cytokine signaling 3 | 0.027 | ||
| STK10 | serine/threonine kinase 10 | 0.026 | ||
| LAMB3 | laminin, beta 3 | 0.026 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.025 | ||
| COTL1 | coactosin-like 1 (Dictyostelium) | 0.025 | ||
| SNX33 | sorting nexin 33 | 0.025 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.024 | ||
| EPHB2 | EPH receptor B2 | 0.024 | Human | |
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.023 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.023 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.022 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.022 | Mouse | |
| SRGN | serglycin | 0.022 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.022 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.021 | ||
| SLC9A1 | solute carrier family 9 (sodium/hydrogen exchanger), member 1 | 0.021 | ||
| FMR1 | fragile X mental retardation 1 | 0.021 | ||
| CAP1 | CAP, adenylate cyclase-associated protein 1 (yeast) | 0.021 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.021 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.020 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.020 | ||
| ANXA5 | annexin A5 | 0.020 | ||
| LAMC2 | laminin, gamma 2 | 0.019 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.019 | ||
| CYFIP1 | cytoplasmic FMR1 interacting protein 1 | 0.019 | ||
| KNG1 | kininogen 1 | 0.018 | ||
| PRKCB | protein kinase C, beta | 0.018 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.018 | Human | |
| CTGF | connective tissue growth factor | 0.018 | ||
| ARPC3 | actin related protein 2/3 complex, subunit 3, 21kDa | 0.018 | ||
| GAS7 | growth arrest-specific 7 | 0.018 | ||
| EFHD2 | EF-hand domain family, member D2 | 0.018 | ||
| CD97 | CD97 molecule | 0.017 | ||
| CD63 | CD63 molecule | 0.017 | ||
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.017 | ||
| SPHK1 | sphingosine kinase 1 | 0.017 | ||
| STC2 | stanniocalcin 2 | 0.017 | ||
| EPHA3 | EPH receptor A3 | 0.017 | Human | |
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.016 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.016 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.016 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.016 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.016 | ||
| EGFR | epidermal growth factor receptor | 0.016 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.016 | ||
| TM4SF1 | transmembrane 4 L six family member 1 | 0.015 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.015 | ||
| CD83 | CD83 molecule | 0.015 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.015 | ||
| COL17A1 | collagen, type XVII, alpha 1 | 0.015 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.015 | Human | |
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.015 | ||
| BMP1 | bone morphogenetic protein 1 | 0.015 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.015 | ||
| ADAM10 | ADAM metallopeptidase domain 10 | 0.015 | ||
| TAPBP | TAP binding protein (tapasin) | 0.015 | ||
| SPRY4 | sprouty homolog 4 (Drosophila) | 0.014 | ||
| TNF | tumor necrosis factor | 0.014 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.014 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.014 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.014 | ||
| VEGFC | vascular endothelial growth factor C | 0.014 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.014 | Human | |
| HOXA1 | homeobox A1 | 0.014 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.014 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.014 | ||
| MATK | megakaryocyte-associated tyrosine kinase | 0.014 | ||
| NNMT | nicotinamide N-methyltransferase | 0.013 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.013 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.013 | ||
| MMP19 | matrix metallopeptidase 19 | 0.013 | ||
| LAMB1 | laminin, beta 1 | 0.013 | ||
| ICAM3 | intercellular adhesion molecule 3 | 0.013 | ||
| FBLIM1 | filamin binding LIM protein 1 | 0.013 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.013 | ||
| IL32 | interleukin 32 | 0.013 | ||
| NRP1 | neuropilin 1 | 0.013 | ||
| CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.013 | ||
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.013 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.013 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.013 | ||
| FLNB | filamin B, beta | 0.013 | ||
| RHOC | ras homolog gene family, member C | 0.013 | ||
| SH3PXD2A | SH3 and PX domains 2A | 0.013 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.013 | Human | |
| ZNF426 | zinc finger protein 426 | 0.013 | ||
| ITGB5 | integrin, beta 5 | 0.013 | Human | |
| FSTL3 | follistatin-like 3 (secreted glycoprotein) | 0.013 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.012 | ||
| CD9 | CD9 molecule | 0.012 | ||
| CORO1A | coronin, actin binding protein, 1A | 0.012 | ||
| ILK | integrin-linked kinase | 0.012 | ||
| GEM | GTP binding protein overexpressed in skeletal muscle | 0.012 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.012 | Human | |
| IL2RA | interleukin 2 receptor, alpha | 0.012 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.012 | ||
| WISP1 | WNT1 inducible signaling pathway protein 1 | 0.012 | ||
| ACTN1 | actinin, alpha 1 | 0.012 | ||
| IL4 | interleukin 4 | 0.012 | ||
| IRF8 | interferon regulatory factor 8 | 0.012 | ||
| SELE | selectin E | 0.012 | ||
| SLAMF7 | SLAM family member 7 | 0.011 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.011 | ||
| LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.011 | ||
| DARC | Duffy blood group, chemokine receptor | 0.011 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.011 | ||
| FMNL1 | formin-like 1 | 0.011 | ||
| IL1A | interleukin 1, alpha | 0.011 | ||
| PDLIM5 | PDZ and LIM domain 5 | 0.011 | ||
| F2 | coagulation factor II (thrombin) | 0.011 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.011 | ||
| ORM1 | orosomucoid 1 | 0.011 | ||
| ITGA8 | integrin, alpha 8 | 0.011 | Human | |
| STC1 | stanniocalcin 1 | 0.011 | ||
| ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) | 0.010 | Human | |
| YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 0.010 | ||
| MYH9 | myosin, heavy chain 9, non-muscle | 0.010 | ||
| JAG1 | jagged 1 | 0.010 | ||
| RDX | radixin | 0.010 | ||
| KYNU | kynureninase | 0.010 | ||
| VASP | vasodilator-stimulated phosphoprotein | 0.010 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.010 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.010 |